메뉴 건너뛰기




Volumn 110, Issue 1, 2013, Pages 206-219

Fed-batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty

Author keywords

Antibody production; Biopharmaceutical manufacture; Cell culture; Fed batch; MySQL database; Perfusion; Process economics; Stochastic discrete event simulation

Indexed keywords

AUTOMOBILE MANUFACTURE; BATCH DATA PROCESSING; CELL CULTURE; CONTINUOUS CELL CULTURE; COST BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT SYSTEMS; DISCRETE EVENT SIMULATION; MONOCLONAL ANTIBODIES; MONTE CARLO METHODS; UNCERTAINTY ANALYSIS;

EID: 84869877665     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24608     Document Type: Article
Times cited : (225)

References (33)
  • 1
    • 84869883325 scopus 로고    scopus 로고
    • How to construct a monoclonal antibody factory: A comparison of production costs in fed batch and perfusion culture with microcarriers-Part two
    • Bosch P, Lundgren B, Kaisermayer C. 2008. How to construct a monoclonal antibody factory: A comparison of production costs in fed batch and perfusion culture with microcarriers-Part two. Bioprocess J 7(2): 30-43.
    • (2008) Bioprocess J , vol.7 , Issue.2 , pp. 30-43
    • Bosch, P.1    Lundgren, B.2    Kaisermayer, C.3
  • 2
    • 84869887862 scopus 로고    scopus 로고
    • Perfusion or fed-batch? A matter of perspective
    • Butler M, editor. London, UK: Taylor Francis Group
    • Cacciuttolo M. 2007. Perfusion or fed-batch? A matter of perspective. In: Butler M, editor. Cell culture and upstream processing. London, UK: Taylor Francis Group. p 173-184.
    • (2007) Cell culture and upstream processing , pp. 173-184
    • Cacciuttolo, M.1
  • 4
    • 84871248564 scopus 로고    scopus 로고
    • (accessed 2011).
    • Centocor ILA. 2006. http://www.epa.ie/licences/lic_eDMS/090151b2800c1411.pdf (accessed 2011).
    • (2006)
    • Centocor, I.L.A.1
  • 5
    • 84869865434 scopus 로고    scopus 로고
    • Process for cell culturing by continuous perfuison and alternating tangential flow patent 20080131934.
    • Crowley J, Wubben M, Coco Martin JM. 2008. Process for cell culturing by continuous perfuison and alternating tangential flow patent 20080131934.
    • (2008)
    • Crowley, J.1    Wubben, M.2    Coco Martin, J.M.3
  • 7
    • 0030019157 scopus 로고    scopus 로고
    • Practical considerations in operation and scale-up of spin-filter based bioreactors for monoclonal antibody production
    • Deo YM, Mahadevan MD, Fuchs R. 1996. Practical considerations in operation and scale-up of spin-filter based bioreactors for monoclonal antibody production. Biotechnol Prog 12(1): 57-64.
    • (1996) Biotechnol Prog , vol.12 , Issue.1 , pp. 57-64
    • Deo, Y.M.1    Mahadevan, M.D.2    Fuchs, R.3
  • 8
    • 33749236399 scopus 로고    scopus 로고
    • Established bioprocesses for producing antibodies as a basis for future planning
    • Farid SS. 2006. Established bioprocesses for producing antibodies as a basis for future planning. Cell Cult Eng 101: 1-42.
    • (2006) Cell Cult Eng , vol.101 , pp. 1-42
    • Farid, S.S.1
  • 9
    • 33847613926 scopus 로고    scopus 로고
    • Process economics of industrial monoclonal antibody manufacture
    • Farid SS. 2007. Process economics of industrial monoclonal antibody manufacture. J Chromatogr B Anal Technol Biomed Life Sci 848(1): 8-18.
    • (2007) J Chromatogr B Anal Technol Biomed Life Sci , vol.848 , Issue.1 , pp. 8-18
    • Farid, S.S.1
  • 10
    • 78649649210 scopus 로고    scopus 로고
    • Economic drivers and trade-offs in antibody purification processes
    • Farid SS. 2009a. Economic drivers and trade-offs in antibody purification processes. Bio Pharm Int S38-S42.
    • (2009) Bio Pharm Int
    • Farid, S.S.1
  • 11
    • 84890735667 scopus 로고    scopus 로고
    • Process economics drivers in industrial monoclonal antibody manufacture
    • Gottschalk U, editor. New Jersey: John Wiley & Sons, Inc. p -
    • Farid SS. 2009b. Process economics drivers in industrial monoclonal antibody manufacture. In: Gottschalk U, editor. Process scale purification of antibodies. New Jersey: John Wiley & Sons, Inc. p 239-262.
    • (2009) Process scale purification of antibodies , pp. 239-262
    • Farid, S.S.1
  • 13
    • 16344374342 scopus 로고    scopus 로고
    • Decision-support tool for assessing biomanufacturing strategies under uncertainty: Stainless steel versus disposable equipment for clinical trial material preparation
    • Farid SS, Washbrook J, Titchener-Hooker NJ. 2005. Decision-support tool for assessing biomanufacturing strategies under uncertainty: Stainless steel versus disposable equipment for clinical trial material preparation. Biotechnol Prog 21(2): 486-497.
    • (2005) Biotechnol Prog , vol.21 , Issue.2 , pp. 486-497
    • Farid, S.S.1    Washbrook, J.2    Titchener-Hooker, N.J.3
  • 14
    • 34248657946 scopus 로고    scopus 로고
    • Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma
    • Farid SS, Washbrook J, Titchener-Hooker NJ. 2007. Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma. Comput Chem Eng 31(9): 1141-1158.
    • (2007) Comput Chem Eng , vol.31 , Issue.9 , pp. 1141-1158
    • Farid, S.S.1    Washbrook, J.2    Titchener-Hooker, N.J.3
  • 17
    • 77953655955 scopus 로고    scopus 로고
    • Industrialization of mAb production technology. The bioprocessing industry at a crossroads
    • Kelley B. 2009. Industrialization of mAb production technology. The bioprocessing industry at a crossroads. Mabs 1(5): 443-452.
    • (2009) Mabs , vol.1 , Issue.5 , pp. 443-452
    • Kelley, B.1
  • 18
    • 35348866110 scopus 로고    scopus 로고
    • Very large scale monoclonal antibody purification: The case for conventional unit operations
    • Kelley BD. 2007. Very large scale monoclonal antibody purification: The case for conventional unit operations. Biotechnol Prog 23(5): 995-1008.
    • (2007) Biotechnol Prog , vol.23 , Issue.5 , pp. 995-1008
    • Kelley, B.D.1
  • 19
    • 33644896550 scopus 로고    scopus 로고
    • A computer-aided approach to compare the production economics of fed-batch and perfusion culture under uncertainty
    • Lim AC, Washbrook J, Titchener-Hooker NJ, Farid SS. 2006. A computer-aided approach to compare the production economics of fed-batch and perfusion culture under uncertainty. Biotechnol Bioeng 93(4): 687-697.
    • (2006) Biotechnol Bioeng , vol.93 , Issue.4 , pp. 687-697
    • Lim, A.C.1    Washbrook, J.2    Titchener-Hooker, N.J.3    Farid, S.S.4
  • 21
    • 77958589701 scopus 로고    scopus 로고
    • Recovery and purification process development for monoclonal antibody production
    • Liu HF, Ma J, Winter C, Bayer R. 2010. Recovery and purification process development for monoclonal antibody production. Mabs 2: 5.
    • (2010) Mabs , vol.2 , pp. 5
    • Liu, H.F.1    Ma, J.2    Winter, C.3    Bayer, R.4
  • 22
    • 0035922884 scopus 로고    scopus 로고
    • Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals
    • Novais JL, Titchener-Hooker NJ, Hoare M. 2001. Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals. Biotechnology Bioeng 75(2): 143-153.
    • (2001) Biotechnology Bioeng , vol.75 , Issue.2 , pp. 143-153
    • Novais, J.L.1    Titchener-Hooker, N.J.2    Hoare, M.3
  • 23
    • 84874980012 scopus 로고    scopus 로고
    • Simulations improve produciton capacity
    • May.
    • Paz A, Puich M. 2004. Simulations improve produciton capacity. BioPharm Int, May.
    • (2004) BioPharm Int
    • Paz, A.1    Puich, M.2
  • 25
    • 0035916371 scopus 로고    scopus 로고
    • Selection of bioprocess simulation software for industrial applications
    • Shanklin T, Roper K, Yegneswaran PK, Marten MR. 2001. Selection of bioprocess simulation software for industrial applications. Biotechnol Bioeng 72(4): 483-489.
    • (2001) Biotechnol Bioeng , vol.72 , Issue.4 , pp. 483-489
    • Shanklin, T.1    Roper, K.2    Yegneswaran, P.K.3    Marten, M.R.4
  • 26
    • 36348937198 scopus 로고    scopus 로고
    • The E factor: Fifteen years on
    • Sheldon RA. 2007. The E factor: Fifteen years on. Green Chem 9(12): 1273-1283.
    • (2007) Green Chem , vol.9 , Issue.12 , pp. 1273-1283
    • Sheldon, R.A.1
  • 27
    • 84869887859 scopus 로고    scopus 로고
    • Fluid filtration system patent 6544424.
    • Shevitz J. 2000. Fluid filtration system patent 6544424.
    • (2000)
    • Shevitz, J.1
  • 30
    • 34250369184 scopus 로고    scopus 로고
    • An on-line method for the reduction of fouling of spin-filters for animal cell perfusion cultures
    • Vallez-Chetreanu F, Ferreira LGF, Rabe R, von Stockar U, Marison IW. 2007. An on-line method for the reduction of fouling of spin-filters for animal cell perfusion cultures. J Biotechnol 130(3): 265-273.
    • (2007) J Biotechnol , vol.130 , Issue.3 , pp. 265-273
    • Vallez-Chetreanu, F.1    Ferreira, L.G.F.2    Rabe, R.3    von Stockar, U.4    Marison, I.W.5
  • 31
    • 0037572331 scopus 로고    scopus 로고
    • Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells
    • Voisard D, Meuwly F, Ruffieux PA, Baer G, Kadouri A. 2003. Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells. Biotechnol Bioeng 82(7): 751-765.
    • (2003) Biotechnol Bioeng , vol.82 , Issue.7 , pp. 751-765
    • Voisard, D.1    Meuwly, F.2    Ruffieux, P.A.3    Baer, G.4    Kadouri, A.5
  • 33
    • 0026737391 scopus 로고
    • Mammalian cell retention in a spinfilter perfusion bioreactor
    • Yabannavar VM, Singh V, Connelly NV. 1992. Mammalian cell retention in a spinfilter perfusion bioreactor. Biotechnol Bioeng 40(8): 925-933.
    • (1992) Biotechnol Bioeng , vol.40 , Issue.8 , pp. 925-933
    • Yabannavar, V.M.1    Singh, V.2    Connelly, N.V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.